Background: Intracranial aneurysm with and without subarachnoid haemorrhage (SAH) is a relevant health problem: The overall incidence is about 9 per 100,000 with a wide range, in some countries up to 20 per 100,000. Mortality rate with conservative treatment within the first months is 50–60%. About one third of patients left with an untreated aneurysm will die from recurrent bleeding within 6 months after recovering from the first bleeding. The prognosis is further influenced by vasospasm, hydrocephalus, delayed ischaemic deficit and other complications. The aim of these guidelines is to provide comprehensive recommendations on the management of SAH with and without aneurysm as well as on unruptured intracranial aneurysm. Methods: We performed an extensive literature search from 1960 to 2011 using Medline and Embase. Members of the writing group met in person and by teleconferences to discuss recommendations. Search results were graded according to the criteria of the European Federation of Neurological Societies. Members of the Guidelines Committee of the European Stroke Organization reviewed the guidelines. Results: These guidelines provide evidence-based information on epidemiology, risk factors and prognosis of SAH and recommendations on diagnostic and therapeutic methods of both ruptured and unruptured intracranial aneurysms. Several risk factors of aneurysm growth and rupture have been identified. We provide recommendations on diagnostic work up, monitoring and general management (blood pressure, blood glucose, temperature, thromboprophylaxis, antiepileptic treatment, use of steroids). Specific therapeutic interventions consider timing of procedures, clipping and coiling. Complications such as hydrocephalus, vasospasm and delayed ischaemic deficit were covered. We also thought to add recommendations on SAH without aneurysm and on unruptured aneurysms. Conclusion: Ruptured intracranial aneurysm with a high rate of subsequent complications is a serious disease needing prompt treatment in centres having high quality of experience of treatment for these patients. These guidelines provide practical, evidence-based advice for the management of patients with intracranial aneurysm with or without rupture. Applying these measures can improve the prognosis of SAH.

Keywords:
Subarachnoid haemorrhage, Intracranial aneurysm, Perimesencephalic subarachnoid haemorrhage, Management, Guidelines
1.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1711–1737.
2.
Brainin M, Barnes M, Baron JC, Gilhus NE, Hughes R, Selmaj K, Waldemar G: Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004. Eur J Neurol 2004;11:577–581.
3.
Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20.
4.
Lindsay KW, Teasdale G, Knill-Jones RP, Murray L: Observer variability in grading patients with subarachnoid hemorrhage. J Neurosurg 1982;56:628–633.
5.
World Federation of Neurological Surgeons Committee: Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985–986.
6.
Oshiro EM, Walter KA, Piantadosi S, Witham TF, Tamargo RJ: A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series. Neurosurgery 1997;41:140–147, discussion pp 147–148.
7.
Takagi K, Tamura A, Nakagomi T, Nakayama H, Gotoh O, Kawai K, Taneda M, Yasui N, Hadeishi H, Sano K: How should a subarachnoid hemorrhage grading scale be determined? A combinatorial approach based solely on the Glasgow Coma Scale. J Neurosurg 1999;90:680–687.
8.
van Heuven AW, Dorhout Mees SM, Algra A, Rinkel GJ: Validation of a prognostic subarachnoid hemorrhage grading scale derived directly from the Glasgow Coma Scale. Stroke 2008;39:1347–1348.
9.
de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ: Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365–1372.
10.
Fogelholm R, Hernesniemi J, Vapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 1993;24:1649–1654.
11.
Rinkel GJ, Djibuti M, Algra A, van Gijn J: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251–256.
12.
Numminen H, Kotila M, Waltimo O, Aho K, Kaste M: Declining incidence and mortality rates of stroke in Finland from 1972 to 1991. Results of three population-based stroke registers. Stroke 1996;27:1487–1491.
13.
Pakarinen S: Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage. A study based on 589 cases diagnosed in a defined urban population during a defined period. Acta Neurol Scand 1967;43(suppl 29):1–128.
14.
Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660–664.
15.
Huang J, van Gelder JM: The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 2002;51:1101–1105, discussion pp 1105–1107.
16.
Phillips LH 2nd, Whisnant JP, O’Fallon WM, Sundt TM Jr: The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 1980;30:1034–1040.
17.
Jane JA, Kassell NF, Torner JC, Winn HR: The natural history of aneurysms and arteriovenous malformations. J Neurosurg 1985;62:321–323.
18.
Winn HR, Richardson AE, O’Brien W, Jane JA: The long-term prognosis in untreated cerebral aneurysms. II. Late morbidity and mortality. Ann Neurol 1978;4:418–426.
19.
Nishioka H, Torner JC, Graf CJ, Kassell NF, Sahs AL, Goettler LC: Cooperative study of intracranial aneurysms and subarachnoid hemorrhage: a long-term prognostic study. II. Ruptured intracranial aneurysms managed conservatively. Arch Neurol 1984;41:1142–1146.
20.
Inagawa T: Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980–1989 and 1990–1998. Stroke 2001;32:1499–1507.
21.
Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009;8:635–642.
22.
Juvela S: Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. BMJ 1992;304:1663–1667.
23.
Juvela S: Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003;34:1852–1857.
24.
Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongale GL: The International Cooperative Study on the timing of aneurysm surgery. Part 1. Overall management results. J Neurosurg 1990;73:18–36.
25.
Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W: Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1993;79:885–891.
26.
Koffijberg H, Buskens E, Granath F, Adami J, Ekbom A, Rinkel GJ, Blomqvist P: Subarachnoid haemorrhage in Sweden 1987–2002: regional incidence and case fatality rates. J Neurol Neurosurg Psychiatry 2008;79:294–299.
27.
Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A: Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg 1998;89:405–411.
28.
Moussouttas M, Huynh TT, Khoury J, Lai EW, Dombrowski K, Pello S, Pacak K: Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage. Cerebrovasc Dis 2012;33:173–181.
29.
Shim JH, Yoon SM, Bae HG, Yun IG, Shim JJ, Lee KS, Doh JW: Which treatment modality is more injurious to the brain in patients with subarachnoid hemorrhage? Degree of brain damage assessed by serum S100 protein after aneurysm clipping or coiling. Cerebrovasc Dis 2012;34:38–47.
30.
Juvela S, Siironen J, Kuhmonen J: Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005;102:998–1003.
31.
Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ: Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003;61:1132–1133.
32.
Juvela S, Siironen J: D-dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage. Stroke 2006;37:1451–1456.
33.
Meyer B, Ringel F, Winter Y, Spottke A, Gharevi N, Dams J, Balzer-Geldsetzer M, Mueller IK, Klockgether T, Schramm J, Urbach H, Dodel R: Health-related quality of life in patients with subarachnoid haemorrhage. Cerebrovasc Dis 2010;30:423–431.
34.
Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS: Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005;36:2773–2780.
35.
Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, Jauch E, Moomaw CJ, Shukla R, Gebel J, Fontaine R, Broderick J: Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke 2002;33:1321–1326.
36.
Juvela S, Hillbom M, Numminen H, Koskinen P: Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke 1993;24:639–646.
37.
Bonita R: Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke 1986;17:831–835.
38.
Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G: Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke 1992;23:1242–1249.
39.
Ruigrok YM, Buskens E, Rinkel GJ: Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke 2001;32:1173–1175.
40.
Juvela S: Risk factors for multiple intracranial aneurysms. Stroke 2000;31:392–397.
41.
Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O’Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–110.
42.
Juvela S, Porras M, Poussa K: Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg 2000;93:379–387.
43.
Juvela S, Poussa K, Porras M: Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke 2001;32:485–491.
44.
Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJ: Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain 2005;128:2421–2429.
45.
Wang PS, Longstreth WT Jr, Koepsell TD: Subarachnoid hemorrhage and family history. A population-based case-control study. Arch Neurol 1995;52:202–204.
46.
Ronkainen A, Hernesniemi J, Ryynanen M: Familial subarachnoid hemorrhage in east Finland, 1977–1990. Neurosurgery 1993;33:787–796, discussion pp 796–797.
47.
Ronkainen A, Miettinen H, Karkola K, Papinaho S, Vanninen R, Puranen M, Hernesniemi J: Risk of harboring an unruptured intracranial aneurysm. Stroke 1998;29:359–362.
48.
Carmelli D, Swan GE, Robinette D, Fabsitz R: Genetic influence on smoking – a study of male twins. N Engl J Med 1992;327:829–833.
49.
Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI: Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke 2003;34:1375–1381.
50.
Bromberg JE, Rinkel GJ, Algra A, van den Berg UA, Tjin ATML, van Gijn J: Hypertension, stroke, and coronary heart disease in relatives of patients with subarachnoid hemorrhage. Stroke 1996;27:7–9.
51.
Sundquist J, Li X, Sundquist K, Hemminki K: Risks of subarachnoid hemorrhage in siblings: a nationwide epidemiological study from Sweden. Neuroepidemiology 2007;29:178–184.
52.
Schievink WI, Schaid DJ, Michels VV, Piepgras DG: Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg 1995;83:426–429.
53.
Raaymakers TW: Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic resonance angiography in relatives of patients with subarachnoid hemorrhage. Neurology 1999;53:982–988.
54.
Greebe P, Bromberg JE, Rinkel GJ, Algra A, van Gijn J: Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives. J Neurol Neurosurg Psychiatry 1997;62:273–275.
55.
Bromberg JE, Rinkel GJ, Algra A, Greebe P, Beldman T, van Gijn J: Validation of family history in subarachnoid hemorrhage. Stroke 1996;27:630–632.
56.
Bromberg JE, Rinkel GJ, Algra A, Greebe P, van Duyn CM, Hasan D, Limburg M, ter Berg HW, Wijdicks EF, van Gijn J: Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ 1995;311:288–289.
57.
Bor AS, Rinkel GJ, Adami J, Koffijberg H, Ekbom A, Buskens E, Blomqvist P, Granath F: Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain 2008;131:2662–2665.
58.
Tokuda Y, Stein GH: Serum lipids as protective factors for subarachnoid hemorrhage. J Clin Neurosci 2005;12:538–541.
59.
Tsutsumi K, Ueki K, Morita A, Usui M, Kirino T: Risk of aneurysm recurrence in patients with clipped cerebral aneurysms: results of long-term follow-up angiography. Stroke 2001;32:1191–1194.
60.
Wermer MJ, Koffijberg H, van der Schaaf IC: Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology 2008;70:2053–2062.
61.
van der Wee N, Rinkel GJ, Hasan D, van Gijn J: Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry 1995;58:357–359.
62.
Vermeulen M, van Gijn J: The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:365–372.
63.
Fifi JT, Meyers PM, Lavine SD, Cox V, Silverberg L, Mangla S, Pile-Spellman J: Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol 2009;20:442–447.
64.
Dammert S, Krings T, Moller-Hartmann W, Ueffing E, Hans FJ, Willmes K, Mull M, Thron A: Detection of intracranial aneurysms with multislice CT: comparison with conventional angiography. Neuroradiology 2004;36:427–434.
65.
White PM, Teasdale EM, Wardlaw JM, Easton V: Intracranial aneurysms: CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort. Radiology 2001;219:739–749.
66.
Agid R, Andersson T, Almqvist H, Willinsky RA, Lee SK, terBrugge KG, Farb RI, Soderman M: Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: when is digital subtraction angiography still needed? AJNR Am J Neuroradiol 2010;31:696–705.
67.
Sarker SJ, Heuschmann PU, Burger I, Wolfe CD, Rudd AG, Smeeton NC, Toschke AM: Predictors of survival after haemorrhagic stroke in a multi-ethnic population: the South London Stroke Register (SLSR). J Neurol Neurosurg Psychiatry 2008;79:260–265.
68.
Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, Parra A, Connolly ES, Mayer SA: Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery 2008;62:80–87, discussion p 87.
69.
Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA: Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617–623, quiz p 624.
70.
Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G: The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156–160.
71.
Dorhout Mees SM, Luitse MJ, van den Bergh WM, Rinkel GJ: Fever after aneurysmal subarachnoid hemorrhage: relation with extent of hydrocephalus and amount of extravasated blood. Stroke 2008;39:2141–2143.
72.
Todd MM, Hindman BJ, Clarke WR, Torner JC: Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005;352:135–145.
73.
Wijdicks EF, Vermeulen M, Murray GD, Hijdra A, van Gijn J: The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1990;92:111–117.
74.
Varon J, Marik PE: Clinical review: the management of hypertensive crises. Crit Care 2003;7:374–384.
75.
Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R: No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 2003;99:953–959.
76.
Juvela S, Siironen J, Varis J, Poussa K, Porras M: Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 2005;102:194–201.
77.
Dickinson LD, Miller LD, Patel CP, Gupta SK: Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998;43:1074–1081.
78.
Black PM, Baker MF, Snook CP: Experience with external pneumatic calf compression in neurology and neurosurgery. Neurosurgery 1986;18:440–444.
79.
Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA: Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2010:CD001922.
80.
Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, Rouhart F, Besson G, Garcia JF, Mottier D, Oger E: Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005;65:865–869.
81.
Butzkueven H, Evans AH, Pitman A, Leopold C, Jolley DJ, Kaye AH, Kilpatrick CJ, Davis SM: Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000;55:1315–1320.
82.
Lin CL, Dumont AS, Lieu AS, Yen CP, Hwang SL, Kwan AL, Kassell NF, Howng SL: Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:978–985.
83.
Claassen J, Jette N, Chum F, Green R, Schmidt M, Choi H, Jirsch J, Frontera JA, Connolly ES, Emerson RG, Mayer SA, Hirsch LJ: Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007;69:1356–1365.
84.
Dennis LJ, Claassen J, Hirsch LJ, Emerson RG, Connolly ES, Mayer SA: Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002;51:1136–1143, discussion p 1144.
85.
Claassen J, Hirsch LJ, Frontera JA, Fernandez A, Schmidt M, Kapinos G, Wittman J, Connolly ES, Emerson RG, Mayer SA: Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care 2006;4:103–112.
86.
Kull LL, Emerson RG: Continuous EEG monitoring in the intensive care unit: technical and staffing considerations. J Clin Neurophysiol 2005;22:107–118.
87.
Molyneux AJ, Kerr RS, Yu L-M, Clarke M, Sneade M, Yarnold JA, Sandercock P, International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2,143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809–817.
88.
Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MD: Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 1992;55:753–757.
89.
Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, Macdonald RL: Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007;107:253–260.
90.
Feigin VL, Anderson NE, Rinkel GJE, Algra A, van Gjn J, Bennett DA: Corticosteroids for aneurysmal subarachnoid hemorrhage and primary intracerebral hemorrhage. Cochrane Database of Syst Rev 2005:CD004583.
91.
Katayama Y, Haraoka J, Hirabayashi H, Kawamata T, Kawamoto K, Kitahara T, Kojima J, Kuroiwa T, Mori T, Moro N, Nagata I, Ogawa A, Ohno K, Seiki Y, Shiokawa Y, Teramoto A, Tominaga T, Yoshimine T: A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2373–2375.
92.
Ohkuma H, Tsurutani H, Suzuki S: Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32:1176–1180.
93.
Hijdra A, Vermeulen M, van Gijn J, van Crevel H: Rerupture of intracranial aneurysms: a clinicoanatomic study. J Neurosurg 1987;67:29–33.
94.
de Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A: Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery 2002;50:336–340, discussion pp 340–332.
95.
Laidlaw JD, Siu KH: Poor-grade aneurysmal subarachnoid hemorrhage: outcome after treatment with urgent surgery. Neurosurgery 2003;53:1275–1280, discussion pp 1280–1272.
96.
Raabe A, Nakaji P, Beck J, Kim LJ, Hsu FP, Kamerman JD, Seifert V, Spetzler RF: Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. J Neurosurg 2005;103:982–989.
97.
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2,143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–1274.
98.
Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, Rischmiller J: Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009;8:427–433.
99.
Campi A, Ramzi N, Molyneux AJ, Summers PE, Kerr RS, Sneade M, Yarnold JA, Rischmiller J, Byrne JV: Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT). Stroke 2007;38:1538–1544.
100.
Mitchell P, Kerr R, Mendelow AD, Molyneux A: Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International Subarachnoid Aneurysm Trial? J Neurosurg 2008;108:437–442.
101.
Choudhari KA, Ramachandran MS, McCarron MO, Kaliaperumal C: Aneurysms unsuitable for endovascular intervention: surgical outcome and management challenges over a 5-year period following International Subarachnoid Haemorrhage Trial (ISAT). Clin Neurol Neurosurg 2007;109:868–875.
102.
O’Kelly CJ, Kulkarni AV, Austin PC, Wallace MC, Urbach D: The impact of therapeutic modality on outcomes following repair of ruptured intracranial aneurysms: an administrative data analysis. Clinical article. J Neurosurg 2010;113:795–801.
103.
Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR: Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture after Treatment (CARAT) study. Stroke 2008;39:120–125.
104.
Elijovich L, Higashida RT, Lawton MT, Duckwiler G, Giannotta S, Johnston SC: Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke 2008;39:1501–1506.
105.
Guo XB, Fan YM, Zhang JN: HydroSoft coil versus HydroCoil for endovascular aneurysm occlusion study: a single center experience. Eur J Radiol 2011;79:e42–46.
106.
Geyik S, Ertugrul O, Yavuz K, Geyik P, Saatci I, Cekirge HS: Comparison of bioactive coils and bare platinum coils for treatment of intracranial aneurysms: a matched-pair analysis. J Neurosurg 2010;112:709–713.
107.
Ryttlefors M, Enblad P, Kerr RS, Molyneux AJ: International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients. Stroke 2008;39:2720–2726.
108.
Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J: Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003:CD001245.
109.
Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002;97:771–778.
110.
Rinkel GJ, Klijn CJ: Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage. Pract Neurol 2009;9:195–209.
111.
Pickard JD, Kirkpatrick PJ, Melsen T, Andreasen RB, Gelling L, Fryer T, Matthews J, Minhas P, Hutchinson PJ, Menon D, Downey SP, Kendall I, Clark J, Carpenter TA, Williams E, Persson L: Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage. Blood Coagul Fibrinolysis 2000;11(suppl 1):S117–S120.
112.
Heros RC: Acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989;20:715–717.
113.
Hasan D, Tanghe HL: Distribution of cisternal blood in patients with acute hydrocephalus after subarachnoid hemorrhage. Ann Neurol 1992;31:374–378.
114.
Rinkel GJ, Wijdicks EF, Vermeulen M, Tans JT, Hasan D, van Gijn J: Acute hydrocephalus in nonaneurysmal perimesencephalic hemorrhage: evidence of CSF block at the tentorial hiatus. Neurology 1992;42:1805–1807.
115.
Auer LM, Mokry M: Disturbed cerebrospinal fluid circulation after subarachnoid hemorrhage and acute aneurysm surgery. Neurosurgery 1990;26:804–808, discussion pp 808–809.
116.
Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ: Management, morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 1990;73:559–566.
117.
Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent JL: Ventriculostomy-related infections in critically ill patients: a 6-year experience. J Neurosurg 2005;103:468–472.
118.
Huttner HB, Schwab S, Bardutzky J: Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care 2006;5:193–196.
119.
Huttner HB, Nagel S, Tognoni E, Kohrmann M, Juttler E, Orakcioglu B, Schellinger PD, Schwab S, Bardutzky J: Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke 2007;38:183–187.
120.
Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007:CD000277.
121.
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636–642.
122.
Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P: Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330–336.
123.
Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T: Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005;56:895–902, discussion pp 895–902.
124.
Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB: Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 2009;29:1444–1453.
125.
Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB: Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2010;41:e47–e52.
126.
Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ: Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2007;78:729–731.
127.
Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Salman RA, Lavados PM, Rinkel GJ, van den Bergh WM: Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 2012;380:44–49.
128.
Kosnik EJ, Hunt WE: Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976;45:148–154.
129.
Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE: Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 1999;44:1113–1116.
130.
Wartenberg KE, Parra A: CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging 2006;16:170–175.
131.
Rinkel GJ, Wijdicks EF, Hasan D, Kienstra GE, Franke CL, Hageman LM, Vermeulen M, van Gijn J: Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991;338:964–968.
132.
van Gijn J, Kerr RS, Rinkel GJ: Subarachnoid haemorrhage. Lancet 2007;369:306–318.
133.
Flaherty ML, Haverbusch M, Kissela B, Kleindorfer D, Schneider A, Sekar P, Moomaw CJ, Sauerbeck L, Broderick JP, Woo D: Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis 2005;14:267–271.
134.
Kaufmann TJ, Huston J 3rd, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF: Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007;243:812–819.
135.
Dawkins AA, Evans AL, Wattam J, Romanowski CA, Connolly DJ, Hodgson TJ, Coley SC: Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 2007;49:753–759.
136.
Ruigrok YM, Rinkel GJ, Buskens E, Velthuis BK, van Gijn J: Perimesencephalic hemorrhage and CT angiography: a decision analysis. Stroke 2000;31:2976–2983.
137.
Velthuis BK, Rinkel GJ, Ramos LM, Witkamp TD, van Leeuwen MS: Perimesencephalic hemorrhage. Exclusion of vertebrobasilar aneurysms with CT angiography. Stroke 1999;30:1103–1109.
138.
Huttner HB, Hartmann M, Kohrmann M, Neher M, Stippich C, Hahnel S, Kress B: Repeated digital substraction angiography after perimesencephalic subarachnoid hemorrhage? J Neuroradiol 2006;33:87–89.
139.
Schwartz TH, Solomon RA: Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature. Neurosurgery 1996;39:433–440, discussion p 440.
140.
Hui FK, Tumialan LM, Tanaka T, Cawley CM, Zhang YJ: Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage. Neurocrit Care 2009;11:64–70.
141.
Kang DH, Park J, Lee SH, Park SH, Kim YS, Hamm IS: Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis? J Clin Neurosci 2009;16:904–908.
142.
Hsu W, Pradilla G, Garonzik IM, Conway JE: Pretruncal nonaneurysmal subarachnoid hemorrhage causing basilar artery vasospasm. Neurocrit Care 2010;13:256–260.
143.
Mayor S, Erro ME, Zazpe I, Gallego J: Pontine stroke due to vasospasm secondary to perimesencephalic subarachnoid hemorrhage (in Spanish). Neurologia 2008;23:256–258.
144.
Rinkel GJ, Wijdicks EF, Vermeulen M, Hasan D, Brouwers PJ, van Gijn J: The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol 1991;29:463–468.
145.
Greebe P, Rinkel GJ: Life expectancy after perimesencephalic subarachnoid hemorrhage. Stroke 2007;38:1222–1224.
146.
van der Schaaf IC, Velthuis BK, Gouw A, Rinkel GJ: Venous drainage in perimesencephalic hemorrhage. Stroke 2004;35:1614–1618.
147.
Urbach H, Zentner J, Solymosi L: The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology 1998;40:6–10.
148.
Topcuoglu MA, Ogilvy CS, Carter BS, Buonanno FS, Koroshetz WJ, Singhal AB: Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg 2003;98:1235–1240.
149.
Kaim A, Proske M, Kirsch E, von Weymarn A, Radu EW, Steinbrich W: Value of repeat-angiography in cases of unexplained subarachnoid hemorrhage (SAH). Acta Neurol Scand 1996;93:366–373.
150.
Jung JY, Kim YB, Lee JW, Huh SK, Lee KC: Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases. J Clin Neurosci 2006;13:1011–1017.
151.
Inamasu J, Nakamura Y, Saito R, Horiguchi T, Kuroshima Y, Mayanagi K, Orii M, Ichikizaki K: ‘Occult’ ruptured cerebral aneurysms revealed by repeat angiography: result from a large retrospective study. Clin Neurol Neurosurg 2003;106:33–37.
152.
International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms – risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725–1733.
153.
Juvela S, Porras M, Heiskanen O: Natural history of unruptured intracranial aneurysms: a long-term follow-up study. J Neurosurg 1993;79:174–182.
154.
Juvela S: Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and rupture. Acta Neurochir Suppl 2002;82:27–30.
155.
Bavinzski G, Talazoglu V, Killer M, Richling B, Gruber A, Gross CE, Plenk H Jr: Gross and microscopic histopathological findings in aneurysms of the human brain treated with Guglielmi detachable coils. J Neurosurg 1999;91:284–293.
156.
Raaymakers TW, Rinkel GJ, Limburg M, Algra A: Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke 1998;29:1531–1538.
157.
Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–84.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.